HopeStage
Back to all studies
CompletedNCT05680727

Personalized brain stimulation targeting depression-related brain networks

About this titleRead the official source — NCT05680727
Interventional studyAges 22–80United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 22 years to 80 years.

Listed locations
BostonSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: July 15, 2023
Recruitment status
Completed
Enrollment listed in the registry
40
Sponsor
Brigham and Women's Hospital
Sponsor type
Hospital / academic medical center
Study type
Procedure
Intervention type
Procedure
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 22 Years to 80 Years
Official registry ID
NCT05680727
Official title
Show the full official title

The Role of Individualized Functional Connectivity Targeting in Accelerated Intelligent Neuromodulation Therapy (AINT) for Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Boston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Brigham and Women's Hospital, a hospital or academic medical center.

Who was this study for?

Listed age limits: 22 years to 80 years.

Want to explore more studies?

Explore studies